A Pilot Study to Detect HSV During Labor Using PCR


To reduce the risk of neonatal HSV transmission among infants whose mothers received intrapartum acyclovir, early detection of neonatal HSV due to enhanced observation, increased knowledge about HSV infection in pregnancy and about HSV transmission to the neonate. Eligible subjects will received IV acyclovir during labor, and their babies will receive oral acyclovir for the first 10 days of life.


HSV, infants, intrapartum acyclovir, neonatal, labor

Principal Investigator




Contact Information

(904) 244-3117

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams